Broker Forecast - finnCap issues a broker note on Shield Therapeutics Plc

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

finnCap today initiates coverage of Shield Therapeutics Plc (LON:STX) with a corporate investment rating and price target of 200p.

Broker Forecasts data provided by www.sharesmagazine.co.uk